Drugs / CNTO 0007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01273467 | Dec 2010 → Jul 2013 | brain infarction, brain ischemia, ischemic stroke | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNTO 0007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01273467 ↗ |
| Known as | 42037788 | “This is a first-in-human (FIH) study of 42037788 (referred to as CNTO 0007), a cell therapy being tested to see if it may be useful in treating patients with ischemic cerebral...” NCT01273467 ↗ |
| Route | Intravenous | “by intravenous (IV) infusion” NCT01273467 ↗ |